| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 16 |
| 1 | PREDNISOLONE | 16 |
| 2 | PREDNISOLONE ORAL | 16 |
| 3 | PREDNISOLONE ORAL SOLUTION | 16 |
| 4 | METHOTREXATE | 15 |
| 5 | ADALIMUMAB | 13 |
| 6 | FUROSEMIDE | 13 |
| 7 | ETOPOSIDE | 7 |
| 8 | INFLIXIMAB | 6 |
| 9 | OMEPRAZOLE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NATURAL VEGETABLE LAXATIVE | 1 | 0.0244 |
| 1 | MITOTANE | 3 | 0.0016 |
| 2 | PENICILLAMINE | 1 | 0.0011 |
| 3 | CLEMASTINE FUMARATE | 1 | 0.0007 |
| 4 | FLURBIPROFEN | 1 | 0.0007 |
| 5 | SENNOSIDES A AND B | 1 | 0.0006 |
| 6 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 1 | 0.0005 |
| 7 | DHEA (DEHYDROEPIANDROSTERONE) | 1 | 0.0005 |
| 8 | ETHAMBUTOL HYDROCHLORIDE | 1 | 0.0004 |
| 9 | ETODOLAC | 2 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 30 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 16 |
| 3 | Loop Diuretic [EPC] | 14 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 12 |
| 5 | Platinum-based Drug [EPC] | 11 |
| 6 | Proton Pump Inhibitor [EPC] | 11 |
| 7 | Topoisomerase Inhibitor [EPC] | 8 |
| 8 | Microtubule Inhibitor [EPC] | 7 |
| 9 | Kinase Inhibitor [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 1 | Prostaglandin E1 Analog [EPC] | 3 | 0.0002 |
| 2 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 3 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 4 | Topoisomerase Inhibitor [EPC] | 8 | 0.0001 |
| 5 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 6 | Bile Acid [EPC] | 2 | 0.0001 |
| 7 | Antimycobacterial [EPC] | 2 | 0.0001 |
| 8 | Iron Chelator [EPC] | 2 | 0.0001 |
| 9 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |